How many insider trades does FilingIQ track for PHGE?

FilingIQ tracks 141 Form 4 insider transactions for PHGE (BiomX Inc.), covering filings from Nov 18, 2019 onwards. 15 of those were filed in the last 90 days.

Are PHGE insiders net buyers or net sellers?

Across the full Form 4 history for PHGE, 31 transactions (22%) were open-market purchases and 73 (52%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does PHGE insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is PHGE in?

BiomX Inc. (PHGE) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $9.86M.

PHGE insider trading

NYSE American Healthcare

BiomX Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

141

Last 90 days

Buys / sells

22% / 52%

Market cap

$9.86M

About BiomX Inc.

BiomX Inc., a clinical-stage biopharmaceutical company, develops phage-based therapies using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company's phage-based therapies include fixed cocktail therapy, which involves developing a single product containing a fixed number of selected phages to cover a range of bacterial strains; and personalized therapy, which involves developing a large library of phages from which single optimal phages are personally matched to treat specific patients. It develops BX011, a fixed multi-phage cocktail, which is in Phase 2a trial for the treatment of diabetic foot infections; and BX211, a phage therapy, which is in Phase 2 trial for the treatment of diabetic foot osteomyelitis. BiomX Inc. was founded in 2015 and is based in Dover, Delaware.

Company website: www.biomx.com

PHGE insider activity at a glance

FilingIQ has scored 141 insider transactions for PHGE since Nov 18, 2019. The most recent filing in our index is dated Mar 17, 2026.

Across the full history, 31 open-market purchases and 73 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PHGE insider trades is 52.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live PHGE trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading PHGE

Yeganeh Reuven

16 trades · score 69.5

Frequently asked

How many insider trades does FilingIQ track for PHGE?: FilingIQ tracks 141 Form 4 insider transactions for PHGE (BiomX Inc.), covering filings from Nov 18, 2019 onwards. 15 of those were filed in the last 90 days.
Are PHGE insiders net buyers or net sellers?: Across the full Form 4 history for PHGE, 31 transactions (22%) were open-market purchases and 73 (52%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PHGE insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is PHGE in?: BiomX Inc. (PHGE) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $9.86M.

Methodology & sources

Every PHGE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.